Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M534Revenue $M45.3Net Margin (%)6.6Altman Z-Score5.0
Enterprise Value $M435EPS $0.0Operating Margin %4.2Piotroski F-Score7
P/E(ttm)511Beneish M-Score0.8Pre-tax Margin (%)4.3Higher ROA y-yY
Price/Book5.110-y EBITDA Growth Rate %--Quick Ratio15.6Cash flow > EarningsY
Price/Sales12.45-y EBITDA Growth Rate %--Current Ratio15.6Lower Leverage y-yY
Price/Free Cash Flow47.9y-y EBITDA Growth Rate %--ROA % (ttm)1.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)2.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M69.7ROIC % (ttm)17.5Gross Margin Increase y-yY

Gurus Latest Trades with PGNX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PGNXJulian Robertson 2015-06-30 Sold Out -1.29%$4.95 - $7.82
($6.05)
$ 7.6727%Sold Out0
PGNXJulian Robertson 2014-09-30 Buy 1.8%$4.15 - $5.56
($4.99)
$ 7.6754%New holding1,290,055
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PGNX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PGNX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ISRAEL ROBERT JExecutive Vice President, Medi 2015-06-11Sell2,000$6.8312.3view
ISRAEL ROBERT JExecutive Vice President, Medi 2015-03-13Sell3,000$79.57view
ISRAEL ROBERT JExecutive Vice President, Medi 2015-03-11Sell2,000$6.8312.3view
ISRAEL ROBERT JExecutive Vice President, Medi 2015-03-03Sell5,000$6.4918.18view
ISRAEL ROBERT JExecutive Vice President, Medi 2015-01-12Sell2,000$7.068.64view
ISRAEL ROBERT JExecutive Vice President, Medi 2014-12-11Sell3,000$7.078.49view
ISRAEL ROBERT JExecutive Vice President, Medi 2014-11-21Sell9,000$79.57view
ISRAEL ROBERT JExecutive Vice President, Medi 2014-11-13Sell10,000$6.8312.3view
ISRAEL ROBERT JExecutive Vice President, Medi 2014-11-11Sell5,000$6.5317.46view
Broadfin Healthcare Master Fun10% Owner 2014-07-21Buy1,625,436$4.666.74view

Quarterly/Annual Reports about PGNX:

    News about PGNX:

    Articles On GuruFocus.com
    Tiger Management’s Julian Robertson Buys Alibaba, eBay, MasTec, Sells Tableau Software, Monsanto, Nov 14 2014 
    Ex-Boxer Paul Tudor Jones Delivering Knockout Punches on Wall Street Nov 07 2014 
    Weekly CEO Buys Highlight: CVRR, HBAN, VVTV, SXCP, PGNX Jan 26 2013 
    Weekly CEO Buys Highlight: CVRR, HBAN, VVTV, SXCP, PGNX Jan 27 2013 
    Weekly CEO Buys Highlight: SUSP, ROVI, ZLC, MDW, PGNX Oct 01 2012 
    5 Stocks That Dropped the Most Since Gurus Bought Them Sep 13 2012 
    Dendreon Could Push Higher If New Drug Trials Succeed Apr 23 2012 
    Progenics Pharmaceuticals Inc. (PGNX) CEO Paul J Maddon buys 5,000 Shares Dec 01 2010 
    Progenics Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 08 2010 
    Progenics Pharmaceuticals Inc. (PGNX) CEO Paul J Maddon buys 5,000 Shares Nov 02 2010 

    More From Other Websites
    Progenics Pharmaceuticals, Inc. Earnings Q2, 2015 Aug 28 2015
    PROGENICS PHARMACEUTICALS INC Financials Aug 20 2015
    10-Q for Progenics Pharmaceuticals, Inc. Aug 08 2015
    Edited Transcript of PGNX earnings conference call or presentation 6-Aug-15 12:30pm GMT Aug 06 2015
    Progenics reports 2Q loss Aug 06 2015
    Progenics reports 2Q loss Aug 06 2015
    Progenics Pharmaceuticals Inc Earnings Call scheduled for 8:30 am ET today Aug 06 2015
    PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition Aug 06 2015
    Progenics Pharmaceuticals Announces Second Quarter 2015 Financial Results Aug 06 2015
    Q2 2015 Progenics Pharmaceuticals Inc Earnings Release - Before Market Open Aug 06 2015
    PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Aug 04 2015
    Progenics Pharmaceuticals Announces Exclusive Worldwide Licensing Agreement With Johns Hopkins... Aug 04 2015
    PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jul 28 2015
    Trending Now: PGNX Jul 28 2015
    Mid-Morning Market Update: Markets Rise; Ford Beats Q2 Estimates Jul 28 2015
    Progenics Announces Breakthrough Therapy Designation for Azedra in Pheochromocytoma and... Jul 28 2015
    Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape Jul 22 2015
    Progenics Pharmaceuticals Sets Second Quarter Financial Results Call for August 6 Jul 21 2015
    Moving Average Crossover Alert: Progenics Pharmaceuticals (PGNX) - Tale of the Tape Jul 09 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK